NAT-APIXABAN
Identification of Nat-Apixaban
| No description |
Google image searchProduct monograph
Active ingredient
apixaban, 5 MG
DIN: 02492822
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: NATCO PHARMA (CANADA) INC
Date: 21-SEP-2022
ATC:
- B01 — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD, )
- B01A — ANTITHROMBOTIC AGENTS (ATC, ATC/DDD)
- B01AF — Direct factor Xa inhibitors (ATC, ATC/DDD)
- B01AF02 — APIXABAN (ATC/DDD)
Reference brand drug: Eliquis
